Chemical Name: | methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide |
CAS Number: | 220127-57-1 |
Product Number: | AG00350I(AGN-PC-0JLOJX) |
Synonyms: | |
MDL No: | |
Molecular Formula: | C30H35N7O4S |
Molecular Weight: | 589.7084 |
Imatinib mesylate, also known by its brand name Gleevec, plays a crucial role in chemical synthesis as a potent tyrosine kinase inhibitor. This compound is widely utilized in the pharmaceutical industry for the treatment of certain types of cancer, particularly chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST).In chemical synthesis, Imatinib mesylate serves as a valuable building block for the creation of various related compounds with potential therapeutic applications. Its unique structure and mechanism of action make it a versatile tool for designing and developing new drugs targeting specific cellular pathways and signaling molecules.Researchers and chemists frequently incorporate Imatinib mesylate into their synthetic strategies to explore its interactions with different biological targets and to discover novel drug candidates with improved efficacy and reduced side effects. By harnessing the synthetic capabilities of Imatinib mesylate, scientists can potentially unlock new treatment options for a range of diseases beyond cancer, paving the way for advancements in personalized medicine and targeted therapies.